PerkinElmer CEO Gregory Summe said this week that his company is on track to close its proposed acquisition of Packard BioScience in November. Speaking at the UBS Warburg Conference in New York this week, Somme said all that remains is a final formal approval by the Securities and Exchange Commission.

The Packard acquisition will help PerkinElmer increase its total revenue to $2.5 billion in 2004, Somme said. Current revenues are expected to total $1.5 billion this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.